SCHEMBL6559388

SCHEMBL6559388

CCS(=O)(=O)N(C)C1CC(C)(C)Oc2ccc(C(N)=O)cc21

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 13/20 0.43
KCNQ1 P51787 13/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
KCND3 Q9UK17 1/20 0.41
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR2C P28335 1/20 0.38
TSHR P16473 1/20 0.35
KCNA5 P22460 1/20 0.34
DRD2 P14416 2/20 0.33
DRD3 P35462 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559208 0.93 KCNE1 (0.46) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6558501 0.91 KCNE1 (0.45) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6560808 0.89 KCNE1 (0.41) KCNE1KCNQ1HTR1AHTR1DHTR2C
SCHEMBL6558778 0.88 HTR1A (0.36) KCNE1KCNQ1HTR1AHTR1DHTR2C
SCHEMBL6560813 0.87 KCNE1 (0.42) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6561170 0.86 HTR1D (0.35) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559386 0.85 KCNA5 (0.39) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559607 0.84 KCNE1 (0.47) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559211 0.84 KCNE1 (0.44) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6601004 0.84 KCNE1 (0.46) KCNE1KCNQ1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed